ZMYND8
Basic information
Region (hg38): 20:47209214-47356889
Previous symbols: [ "PRKCBP1" ]
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZMYND8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 44 | 48 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 1 | 0 | 50 | 5 | 5 |
Variants in ZMYND8
This is a list of pathogenic ClinVar variants found in the ZMYND8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-47210777-T-G | not specified | Uncertain significance (Mar 14, 2023) | ||
20-47210799-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
20-47210825-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
20-47210843-G-A | ZMYND8-related disorder | Likely benign (Feb 20, 2023) | ||
20-47212659-T-C | not specified | Uncertain significance (Oct 05, 2021) | ||
20-47212668-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
20-47220296-G-A | not specified | Uncertain significance (May 25, 2022) | ||
20-47220307-G-A | Likely benign (Jul 01, 2022) | |||
20-47221345-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
20-47221364-C-T | not specified | Likely benign (May 25, 2022) | ||
20-47221399-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
20-47224418-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
20-47224458-C-T | not specified | Uncertain significance (Feb 24, 2023) | ||
20-47224498-G-C | Uncertain significance (Jan 25, 2024) | |||
20-47224532-TGCCGCATCTCC-T | Uncertain significance (Jul 22, 2022) | |||
20-47227278-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
20-47236391-C-A | ZMYND8-related disorder | Uncertain significance (Jun 14, 2023) | ||
20-47236391-C-T | not specified | Uncertain significance (May 01, 2024) | ||
20-47236416-C-A | not specified | Uncertain significance (Sep 22, 2023) | ||
20-47236423-C-T | Uncertain significance (Feb 03, 2023) | |||
20-47236444-G-A | not specified | Uncertain significance (Jun 02, 2024) | ||
20-47238794-G-A | Intellectual disability | Uncertain significance (Aug 01, 2017) | ||
20-47238935-T-C | not specified | Uncertain significance (Jan 18, 2023) | ||
20-47238983-C-T | not specified | Uncertain significance (Oct 05, 2022) | ||
20-47238988-G-C | not specified | Uncertain significance (Apr 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZMYND8 | protein_coding | protein_coding | ENST00000461685 | 23 | 147709 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 6.08e-8 | 125737 | 0 | 10 | 125747 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.04 | 399 | 700 | 0.570 | 0.0000419 | 7862 |
Missense in Polyphen | 80 | 234.01 | 0.34187 | 2776 | ||
Synonymous | -0.387 | 294 | 286 | 1.03 | 0.0000204 | 2207 |
Loss of Function | 6.77 | 3 | 59.2 | 0.0507 | 0.00000285 | 719 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000450 | 0.0000439 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May act as a transcriptional corepressor for KDM5D. Required for KDM5D-mediated down-regulation of diverse metastasis- associated genes; the function seems to involve the recognition of the dual histone signature H3K4me1-H3K14ac. Suppresses prostate cancer cell invasion. {ECO:0000269|PubMed:27477906}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.0152
- rvis_EVS
- -1.44
- rvis_percentile_EVS
- 3.98
Haploinsufficiency Scores
- pHI
- 0.162
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zmynd8
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); skeleton phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;negative regulation of cell migration;positive regulation of filopodium assembly;positive regulation of dendritic spine development;modulation of excitatory postsynaptic potential;regulation of postsynaptic density protein 95 clustering;positive regulation of dendritic spine maintenance;negative regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;cytoplasm;dendritic spine;dendritic shaft
- Molecular function
- transcription corepressor activity;protein binding;zinc ion binding;protein domain specific binding;methylated histone binding;protein N-terminus binding;repressing transcription factor binding;lysine-acetylated histone binding